|
Market Cap (21-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 16 May 2022, 15:34. The announcement is not marked as price sensitive, and is 14 page(s) in length and 2.88MB in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Biotech Investors Luncheon Presentations | 16 May 2022, 15:34 |
| GTG: Biotech Investors Presentation | 16 May 2022, 9:07 |
| Medlab Signs NRG Biotic Trade Deal with Cultech Ltd | 20 April 2022, 9:14 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 14 April 2022, 15:45 |
You must be logged in to post a reply.
Medlab Clinical 